167 related articles for article (PubMed ID: 28834373)
1. ADHD Medication, Dietary Patterns, Physical Activity, and BMI in Children: A Longitudinal Analysis of the ECLS-K Study.
Bowling A; Davison K; Haneuse S; Beardslee W; Miller DP
Obesity (Silver Spring); 2017 Oct; 25(10):1802-1808. PubMed ID: 28834373
[TBL] [Abstract][Full Text] [Related]
2. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
[TBL] [Abstract][Full Text] [Related]
3. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
Rose SR; Reeves G; Gut R; Germak J
J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
[TBL] [Abstract][Full Text] [Related]
4. Children With Attention-Deficit/Hyperactivity Disorder Are at Increased Risk for Slowed Growth and Short Stature in Early Childhood.
Davallow Ghajar L; DeBoer MD
Clin Pediatr (Phila); 2020 May; 59(4-5):401-410. PubMed ID: 32009447
[TBL] [Abstract][Full Text] [Related]
5. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
6. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
McCabe SE; Dickinson K; West BT; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
[TBL] [Abstract][Full Text] [Related]
7. The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity.
Kollin SR; Lim CS; Lee AA
Pediatr Obes; 2023 Sep; 18(9):e13058. PubMed ID: 37263740
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Stimulant Medications on Blood Pressure and Body Mass Index in Children with Attention Deficit Hyperactivity Disorder.
Suess M; Chrenka EA; Kharbanda EO; Asche S; O'Connor PJ; Ekstrom H; Benziger CP
Acad Pediatr; 2024 Apr; 24(3):424-432. PubMed ID: 37652161
[TBL] [Abstract][Full Text] [Related]
9. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
[TBL] [Abstract][Full Text] [Related]
10. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit hyperactivity disorder medications and BMI trajectories: The role of medication type, sex and age.
Gurka MJ; Siddiqi SU; Filipp SL; Mercado R; Thompson LA; Janicke DM; Shenkman EA
Pediatr Obes; 2021 Apr; 16(4):e12738. PubMed ID: 33064373
[TBL] [Abstract][Full Text] [Related]
12. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.
Raman SR; Marshall SW; Haynes K; Gaynes BN; Naftel AJ; Stürmer T
Inj Prev; 2013 Jun; 19(3):164-70. PubMed ID: 23143347
[TBL] [Abstract][Full Text] [Related]
13. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
[TBL] [Abstract][Full Text] [Related]
14. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
[TBL] [Abstract][Full Text] [Related]
15. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
[TBL] [Abstract][Full Text] [Related]
17. Increased resting energy expenditure in children with attention-deficit-hyperactivity disorder.
Mueller TF; Brielmaier S; Domsch H; Luyckx VA; Ehlers T; Krowatschek D
Eat Weight Disord; 2010 Sep; 15(3):e144-51. PubMed ID: 20212347
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
19. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Palli SR; Kamble PS; Chen H; Aparasu RR
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term psychostimulant medication on growth of children with ADHD.
Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
